Eli Lilly and vs UnitedHealth Group Incorporated at a glance
Both companies operate in the Health Care sector, so these figures are broadly like-for-like.
| Metric | LLY | UNH |
|---|---|---|
| Market cap | $1.05T | $356.01B |
| Price | $1,174.61 | $392.95 |
| P/E ratio (TTM) | 46.69 | 24.76 |
| P/B ratio (MRQ) | 36.31 | 3.17 |
| P/S ratio (TTM) | 14.78 | 0.67 |
| Revenue growth (1Y) | 44.70% | 11.81% |
| Return on equity (TTM) | 77.78% | 12.81% |
| Return on invested capital (TTM) | 34.50% | 9.58% |
| Gross margin (TTM) | 84.01% | 22.49% |
| Net margin (TTM) | 33.53% | 3.14% |
| Dividend yield (TTM) | 0.59% | 2.36% |
How they differ
Eli Lilly and is the larger company at $1.05T versus $356.01B — about 2.9x the size.
On trailing earnings, UnitedHealth Group Incorporated is the cheaper of the two at 24.76 against 46.69 for Eli Lilly and.
On sales, UnitedHealth Group Incorporated is the cheaper of the two at 0.67 against 14.78 for Eli Lilly and.
Eli Lilly and leads on revenue growth over the past year, 44.70% against 11.81%.
Eli Lilly and leads on return on invested capital, 34.50% against 9.58%.
Eli Lilly and leads on gross margin, 84.01% against 22.49%.
UnitedHealth Group Incorporated offers the higher yield at 2.36% against 0.59%.
Go deeper
Ratios describe the past. Whether either is worth owning depends on what you pay today.
Related comparisons
Other matchups involving Eli Lilly and or UnitedHealth Group Incorporated.